Alkem’s US Business Doubles And Continues To Grow
As Company Received 10 ANDA Approvals In Q4 FY21
India’s Alkem Laboratories has reported double-digit growth in its US business for financial year 2021, after seeing its US business double in four years. The company also saw recovery in its domestic business on the back of robust growth delivered by its generics business.
